Sicart Associates’s Albemarle ALB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALB
Sicart Associates's ALB Position: Q2 2026 in Review
Sicart Associates reduced its Albemarle (ALB) stake by 5.7% in Q2 2026, selling an estimated $472K and leaving 44,524 shares worth $6.01M. The position accounts for 1.47% of the portfolio, ranked #25.
Sicart Associates first reported a position in ALB in Q1 2020 and has held it in 26 quarters since. The position peaked at $18.8M in Q4 2021. 944 funds tracked by Wall St. Rank hold ALB as of Q2 2026.
- Sicart Associates held 44,524 shares of Albemarle worth $6.01M as of Q2 2026.
- Sicart Associates sold 2,678 Albemarle shares in Q2 2026, an estimated $472K.
- Albemarle made up 1.47% of Sicart Associates's portfolio in Q2 2026, its #25 holding.
- Sicart Associates first reported a position in Albemarle in Q1 2020 and has held it in 26 quarters since.
- Sicart Associates's Albemarle position peaked at $18.8M in Q4 2021.
- 944 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.
Based on Sicart Associates's 13F filing for Q2 2026, filed 11 Aug 2026.